Nice_老虎社区_美港股上老虎

AuAgJCY
2021-11-13

Nice

Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies<blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近 3%</blockquote>

Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into

Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies<blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近 3%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":879767869,"tweetId":"879767869","gmtCreate":1636775101130,"gmtModify":1636775101130,"author":{"id":3585975527733594,"idStr":"3585975527733594","authorId":3585975527733594,"authorIdStr":"3585975527733594","name":"AuAgJCY","avatar":"https://static.tigerbbs.com/d13b96116e3bd1a5a63bde3ee8bd7219","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/879767869","repostId":1157226169,"repostType":4,"repost":{"id":"1157226169","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636715890,"share":"https://www.laohu8.com/m/news/1157226169?lang=zh_CN&edition=full","pubTime":"2021-11-12 19:18","market":"us","language":"en","title":"Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies<blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近 3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1157226169","media":"Tiger Newspress","summary":"Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into","content":"<p>Johnson&nbsp;&amp;&nbsp;Johnson&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;the&nbsp;company&nbsp;planned to break up into two companies.<img src=\"https://static.tigerbbs.com/9d27873f03346ba9d3faeb2b6c841b44\" tg-width=\"879\" tg-height=\"578\" referrerpolicy=\"no-referrer\">Johnson &amp; Johnson&nbsp;plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just&nbsp;how much healthcare has changed&nbsp;since the company helped pioneer the industry.</p><p><blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近3%。强生公司（Johnson &amp; Johnson）计划拆分成两家公司，将销售创可贴绷带、泰诺药品和强生婴儿爽身粉的年销售额达 150 亿美元的部门分拆出来，这一转变表明自该公司帮助开创该行业以来，医疗保健行业发生了多大的变化。</blockquote></p><p> The&nbsp;world’s largest health-products company by sales&nbsp;will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.</p><p><blockquote>按销售额计算，这家全球最大的保健品公司将把高利润但风险较大的处方药和医疗器械业务与其历史悠久但增长较慢的消费者集团分开，创建两家上市公司。</blockquote></p><p> J&amp;J will shed its consumer division in 18 to 24 months, Chief Executive Alex Gorsky said. J&amp;J decided to make the change, he said, because the businesses, their customers and markets have diverged so much in recent years, including during the pandemic. Lawsuits that&nbsp;alleged use of Johnson’s Baby Powder caused cancer&nbsp;didn’t play a role, he said.</p><p><blockquote>强生首席执行官亚历克斯·戈尔斯基 (Alex Gorsky) 表示，强生将在 18 至 24 个月内剥离其消费者部门。他说，强生决定做出改变，因为近年来，包括疫情期间，企业、客户和市场差异很大。他说，指控使用约翰逊婴儿爽身粉致癌的诉讼并没有起到任何作用。</blockquote></p><p> “The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate healthcare company,” Mr. Gorsky said in an interview.</p><p><blockquote>“戈尔斯基先生在接受采访时说：”要确保长期可持续增长，更好地满足病人和消费者的需求，最好的前进道路就是让我们的消费者业务作为一家独立的医疗保健公司运营。</blockquote></p><p> What form the separation will take, what the new company will be called and who will lead it are yet to be worked out, Mr. Gorsky said, though he said J&amp;J planned to structure the transaction to be tax-free.</p><p><blockquote>戈尔斯基表示，分拆将采取何种形式、新公司将被命名为什么以及谁将领导它尚未确定，但他表示强生计划将交易结构为免税。</blockquote></p><p> It is likely J&amp;J would spin out its consumer unit and hold a stock offering, but no decision has been made, Mr. Gorsky said.</p><p><blockquote>戈尔斯基表示，强生很可能会剥离其消费者部门并进行股票发行，但尚未做出任何决定。</blockquote></p><p> The decision comes after rivals including&nbsp;Pfizer&nbsp;Inc.&nbsp;and&nbsp;Merck&nbsp;&amp; Co. decided to hive off their consumer businesses and double down on faster-growing pharmaceuticals.</p><p><blockquote>这一决定是在辉瑞公司 (Pfizer Inc.) 和默克公司 (Merck &amp; Co.) 等竞争对手决定剥离消费者业务并加倍投资增长更快的制药产品之后做出的。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies<blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近 3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies<blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近 3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-12 19:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Johnson&nbsp;&amp;&nbsp;Johnson&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;the&nbsp;company&nbsp;planned to break up into two companies.<img src=\"https://static.tigerbbs.com/9d27873f03346ba9d3faeb2b6c841b44\" tg-width=\"879\" tg-height=\"578\" referrerpolicy=\"no-referrer\">Johnson &amp; Johnson&nbsp;plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just&nbsp;how much healthcare has changed&nbsp;since the company helped pioneer the industry.</p><p><blockquote>强生公司计划拆分为两家公司，其股价在盘前交易中上涨近3%。强生公司（Johnson &amp; Johnson）计划拆分成两家公司，将销售创可贴绷带、泰诺药品和强生婴儿爽身粉的年销售额达 150 亿美元的部门分拆出来，这一转变表明自该公司帮助开创该行业以来，医疗保健行业发生了多大的变化。</blockquote></p><p> The&nbsp;world’s largest health-products company by sales&nbsp;will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.</p><p><blockquote>按销售额计算，这家全球最大的保健品公司将把高利润但风险较大的处方药和医疗器械业务与其历史悠久但增长较慢的消费者集团分开，创建两家上市公司。</blockquote></p><p> J&amp;J will shed its consumer division in 18 to 24 months, Chief Executive Alex Gorsky said. J&amp;J decided to make the change, he said, because the businesses, their customers and markets have diverged so much in recent years, including during the pandemic. Lawsuits that&nbsp;alleged use of Johnson’s Baby Powder caused cancer&nbsp;didn’t play a role, he said.</p><p><blockquote>强生首席执行官亚历克斯·戈尔斯基 (Alex Gorsky) 表示，强生将在 18 至 24 个月内剥离其消费者部门。他说，强生决定做出改变，因为近年来，包括疫情期间，企业、客户和市场差异很大。他说，指控使用约翰逊婴儿爽身粉致癌的诉讼并没有起到任何作用。</blockquote></p><p> “The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate healthcare company,” Mr. Gorsky said in an interview.</p><p><blockquote>“戈尔斯基先生在接受采访时说：”要确保长期可持续增长，更好地满足病人和消费者的需求，最好的前进道路就是让我们的消费者业务作为一家独立的医疗保健公司运营。</blockquote></p><p> What form the separation will take, what the new company will be called and who will lead it are yet to be worked out, Mr. Gorsky said, though he said J&amp;J planned to structure the transaction to be tax-free.</p><p><blockquote>戈尔斯基表示，分拆将采取何种形式、新公司将被命名为什么以及谁将领导它尚未确定，但他表示强生计划将交易结构为免税。</blockquote></p><p> It is likely J&amp;J would spin out its consumer unit and hold a stock offering, but no decision has been made, Mr. Gorsky said.</p><p><blockquote>戈尔斯基表示，强生很可能会剥离其消费者部门并进行股票发行，但尚未做出任何决定。</blockquote></p><p> The decision comes after rivals including&nbsp;Pfizer&nbsp;Inc.&nbsp;and&nbsp;Merck&nbsp;&amp; Co. decided to hive off their consumer businesses and double down on faster-growing pharmaceuticals.</p><p><blockquote>这一决定是在辉瑞公司 (Pfizer Inc.) 和默克公司 (Merck &amp; Co.) 等竞争对手决定剥离消费者业务并加倍投资增长更快的制药产品之后做出的。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157226169","content_text":"Johnson & Johnson shares rose nearly 3% in premarket trading as the company planned to break up into two companies.Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.\nThe world’s largest health-products company by sales will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.\nJ&J will shed its consumer division in 18 to 24 months, Chief Executive Alex Gorsky said. J&J decided to make the change, he said, because the businesses, their customers and markets have diverged so much in recent years, including during the pandemic. Lawsuits that alleged use of Johnson’s Baby Powder caused cancer didn’t play a role, he said.\n“The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate healthcare company,” Mr. Gorsky said in an interview.\nWhat form the separation will take, what the new company will be called and who will lead it are yet to be worked out, Mr. Gorsky said, though he said J&J planned to structure the transaction to be tax-free.\nIt is likely J&J would spin out its consumer unit and hold a stock offering, but no decision has been made, Mr. Gorsky said.\nThe decision comes after rivals including Pfizer Inc. and Merck & Co. decided to hive off their consumer businesses and double down on faster-growing pharmaceuticals.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":3172,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}